Zogg Stefanie, Dürr Selina, Miedinger David, Steveling Esther Helen, Maier Sabrina, Leuppi Jörg Daniel
Medical University Clinic, Cantonal Hospital Baselland, Rheinstrasse 26, Liestal CH - 4410, Switzerland.
BMC Res Notes. 2014 Aug 23;7:562. doi: 10.1186/1756-0500-7-562.
The Global Initiative for Chronic Obstructive Lung Disease proposed in 2011 a new system to classify chronic obstructive pulmonary disease (COPD) patients into risk groups A-D, which considers symptoms and future exacerbation risk to grade disease severity. The aim of this study was to investigate the agreement between COPD risk group classifications using COPD assessment test (CAT) or modified Medical Research Council (mMRC) and severity grades or past-year exacerbations. Furthermore, physical activity across risk groups was examined.
87 patients with stable COPD were classified into risk groups A-D. CAT and mMRC were completed. Severity grades I-IV were determined using spirometry and the number of past-year exacerbations was recorded. To test the interrater agreement, Cohen's Kappa was calculated. Daily physical activity was measured by the SenseWear Mini armband.
Using CAT, 65.5% of patients were in high-symptom groups (B and D). With mMRC, only 37.9% were in B and D. Using severity grades, 20.7% of patients were in high-exacerbation risk groups (C and D). With past-year exacerbations, 9.2% were in C and D. Interrater agreement between CAT and mMRC (κ = 0.21) and between severity grades and past-year exacerbations (κ = 0.31) was fair. Daily steps were reduced in risk groups B and C + D compared to A (p < 0.01), using either classification.
When classifying COPD patients into risk groups A-D, the use of CAT or mMRC and severity grades or past-year exacerbations does not provide equal results. Daily steps decreased with increasing COPD risk groups.
慢性阻塞性肺疾病全球倡议组织在2011年提出了一种新系统,将慢性阻塞性肺疾病(COPD)患者分为A - D风险组,该系统考虑症状和未来急性加重风险来分级疾病严重程度。本研究的目的是调查使用慢性阻塞性肺疾病评估测试(CAT)或改良医学研究委员会(mMRC)进行的COPD风险组分类与严重程度分级或过去一年急性加重情况之间的一致性。此外,还对各风险组的身体活动情况进行了检查。
87例稳定期COPD患者被分为A - D风险组。完成CAT和mMRC评估。使用肺功能仪确定严重程度分级为I - IV级,并记录过去一年急性加重的次数。为测试评分者间的一致性,计算了科恩kappa系数。通过SenseWear Mini臂带测量日常身体活动。
使用CAT时,65.5%的患者属于高症状组(B组和D组)。使用mMRC时,只有37.9%的患者属于B组和D组。根据严重程度分级,20.7%的患者属于高急性加重风险组(C组和D组)。根据过去一年急性加重情况,9.2%的患者属于C组和D组。CAT与mMRC之间(κ = 0.21)以及严重程度分级与过去一年急性加重情况之间(κ = 0.31)的评分者间一致性为中等。使用任何一种分类方法,与A组相比,B组以及C + D组的每日步数均减少(p < 0.01)。
将COPD患者分为A - D风险组时,使用CAT或mMRC以及严重程度分级或过去一年急性加重情况所得到的结果并不相同。随着COPD风险组的增加,每日步数减少。